ArticlePharmaceutics2018

Doxorubicin-Conjugated PAMAM Dendrimers for pH-Responsive Drug Release and Folic Acid-Targeted Cancer Therapy.

Mengen Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.